A Study of a Renal Autologous Cell Therapy (REACT) in Patients With Chronic Kidney Disease (CKD) From Congenital Anomalies of the Kidney and Urinary Tract (CAKUT).

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

August 13, 2019

Primary Completion Date

January 31, 2023

Study Completion Date

January 31, 2023

Conditions
Chronic Kidney DiseaseCongenital Anomalies of Kidney and Urinary Tract
Interventions
BIOLOGICAL

Renal Autologous Cell Therapy (REACT)

Autologous selected renal cells (SRC)

Trial Locations (5)

27599

University of North Carolina- Chapel Hill, Chapel Hill

30322

Emory University Hospital, Atlanta

45246

Mt. Sinai Hospital, New York

83642

Boise Kidney & Hypertension Institute, Meridian

07753

Hackensack Meridian Jersey Shore University Medical Center, Neptune City

Sponsors
All Listed Sponsors
collaborator

CTI Clinical Trial and Consulting Services

OTHER

lead

Prokidney

INDUSTRY